Raras
Buscar doenças, sintomas, genes...
Anemia hemolítica autoimune, tipo quente
ORPHA:90033CID-10 · D59.1CID-11 · 3A20.0DOENÇA RARA

A anemia hemolítica autoimune quente é a forma mais comum de anemia hemolítica autoimune definida pela presença de autoanticorpos quentes contra glóbulos vermelhos (autoanticorpos ativos em temperaturas entre 37-40°C).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A anemia hemolítica autoimune quente é a forma mais comum de anemia hemolítica autoimune definida pela presença de autoanticorpos quentes contra glóbulos vermelhos (autoanticorpos ativos em temperaturas entre 37-40°C).

Publicações científicas
4.180 artigos
Último publicado: 2026 Apr

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: D59.1
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🩸
Sangue
3 sintomas
❤️
Coração
2 sintomas
🫃
Digestivo
2 sintomas
🛡️
Imunológico
1 sintomas
🫘
Rins
1 sintomas
🫁
Pulmão
1 sintomas

+ 17 sintomas em outras categorias

Características mais comuns

90%prev.
Cefaleia
Muito frequente (99-80%)
90%prev.
Palidez
Muito frequente (99-80%)
90%prev.
Fadiga
Muito frequente (99-80%)
90%prev.
Autoimunidade
Muito frequente (99-80%)
90%prev.
Dispneia de esforço
Muito frequente (99-80%)
90%prev.
Anemia hemolítica autoimune
Muito frequente (99-80%)
27sintomas
Muito frequente (6)
Frequente (12)
Ocasional (9)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 27 características clínicas mais associadas, ordenadas por frequência.

CefaleiaHeadache
Muito frequente (99-80%)90%
PalidezPallor
Muito frequente (99-80%)90%
FadigaFatigue
Muito frequente (99-80%)90%
AutoimunidadeAutoimmunity
Muito frequente (99-80%)90%
Dispneia de esforçoExertional dyspnea
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico4.180PubMed
Últimos 10 anos91publicações
Pico202415 papers
Linha do tempo
2026Hoje · 2026🧪 2001Primeiro ensaio clínico📈 2024Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 23
1Fase 11
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 5 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Anemia hemolítica autoimune, tipo quente

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

0 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
197 papers (10 anos)
#1

A Complex Case of Anti-e Mimicking Autoantibody Development Leading to Warm Autoimmune Hemolytic Anemia: Case Report.

Acta haematologica2026 Mar 13

Newly diagnosed autoimmune hemolytic anemia (AIHA) develops in 1-3 individuals per 100,000 people per year. Warm autoimmune hemolytic anemia (WAIHA) is the most common type of AIHA, accounting for approximately 70-80% of cases. This report outlines complex presentation of DTA-negative, anti-e-mimicking autoantibody mediated WAIHA following a transient viral infection in an adult male patient with no prior transfusions. A 55-year-old male patient presented with several weeks of flu-like symptoms followed by jaundice, dyspnea, and fatigue with lab work up notable initially for an anti-C antibody mediated WAIHA but later determined to be an anti-e mimicking pan-agglutinating autoantibody. This report highlights a complex case of a patient with an autoantibody mimicking anti-e associated WAIHA and the challenge of identifying suitable transfusion options.

#2

When Warm Meets Cold: Mixed-Type Autoimmune Hemolytic Anemia Revealing an Underlying Autoimmune Disorder.

Cureus2026 Jan

Autoimmune hemolytic anemia (AIHA) is a rare immune-mediated disorder caused by autoantibodies directed against red blood cell antigens. Mixed-type AIHA, characterized by the coexistence of warm-reactive IgG and cold-reactive complement-fixing antibodies, is uncommon and often diagnostically challenging due to overlapping serologic features and transfusion incompatibility. We report the case of a 40-year-old woman who presented with an acute onset of breathlessness, palpitations, and severe fatigability. She was found to have severe anemia (hemoglobin 2.7 g/dL), reticulocytosis, indirect hyperbilirubinemia, and red cell agglutination on peripheral smear. Both direct and indirect Coombs tests were strongly positive, while antibody screening demonstrated panreactivity with positive autocontrol. The monospecific direct antiglobulin test confirmed positivity for IgG and C3d, establishing the diagnosis of mixed-type AIHA. In view of hemodynamic instability, transfusion with the least-incompatible packed red cells was performed under warming precautions, alongside high-dose intravenous corticosteroids. The patient improved symptomatically, with hemoglobin rising to 8.8 g/dL. Autoimmune workup revealed high-titer antinuclear antibody and anti-SSA positivity, suggesting an evolving systemic autoimmune disorder. Mixed-type AIHA accounts for less than 10% of cases but is associated with significant morbidity due to combined extravascular and complement-mediated hemolysis, often necessitating cautious transfusion of least-incompatible blood in life-threatening anemia and escalation to rituximab or other immunosuppressive agents. This case highlights the diagnostic complexity, therapeutic challenges, and need for long-term autoimmune surveillance in patients with mixed-type AIHA.

#3

A Rare Autoimmune Hemolytic Overlap: Coombs-Positive Pernicious Anemia.

Cureus2026 Jan

Pernicious anemia is a type of autoimmune disease caused by the presence of anti-intrinsic factor and antiparietal cell antibodies, leading to vitamin B12 deficiency and ineffective erythropoiesis. Autoimmune hemolytic anemia is a variant of anemia in which the direct Coombs test is positive. It is uncommon to find a mixed anemia that has both a pernicious anemia component and an autoimmune anemia component with a positive direct Coombs test, as this association is rarely described. Two cases in which this association was found are presented. The first case involved a 65-year-old woman presenting with profound anemia, macrocytosis, reticulocytosis, elevated lactate dehydrogenase, low haptoglobin, and a positive direct Coombs test. She had anti-intrinsic factor antibodies and responded to vitamin B12 supplementation and corticosteroids. The second case involved an 83-year-old woman with severe anemia, vitamin B12 deficiency, positive antiparietal and anti-intrinsic factor antibodies, and positive direct Coombs test, who similarly improved with cobalamin and immunosuppressive therapy. These cases highlight the rare overlap of pernicious anemia and autoimmune hemolytic anemia, emphasizing the importance of recognizing concurrent autoimmune hemolysis in patients with severe vitamin B12 deficiency to guide prompt and appropriate therapy.

#4

Transfusion-induced hemolysis in warm autoimmune hemolytic anemia with autoantibodies that have anti-e specificity: a case report and systematic review of the literature.

Therapeutic advances in hematology2026

Warm autoimmune hemolytic anemia (wAIHA) is characterized by autoantibodies against proteins that comprise the Rh antigen system along with hemolysis. The presence of specific autoantibodies, especially autoantibodies with anti-e specificity, is rare. The pathophysiology, management, and outcomes in this condition, including with transfusion of e-antigen positive packed red blood cells (pRBCs), remain poorly understood. A 63-year-old woman presented with fatigue, jaundice, tea-colored urine, and dyspnea. She was diagnosed with wAIHA with anti-e specificity and developed worsening hemolysis after receiving a unit of e-antigen positive pRBCs with a drop in hemoglobin from 85 to 71 g/L. She achieved a complete response with a tapering course of prednisone and folate. We conducted a systematic review of the literature by searching MEDLINE, EMBASE, and Cochrane for articles on management of wAIHA with anti-e specificity published between 1946 and 2025. We identified eighteen cases of wAIHA mediated through autoantibodies with anti-e specificity, only one of which demonstrated hemolysis after transfusion with e-antigen positive pRBCs. Treatment with corticosteroids and rituximab was effective in many of these cases. This is the one of the few cases to demonstrate increased hemolysis after transfusion with e-antigen positive pRBCs in a patient with wAIHA and autoantibodies with anti-e specificity. In these patients, transfusion of e-antigen positive pRBCs should be avoided and if transfusion is necessary, it will be important to closely monitor for worsening hemolysis. Additionally, our case and those reported in the literature highlight the effectiveness of standard corticosteroid treatment for this rare type of wAIHA.

#5

Disseminated intravascular coagulation secondary to postpartum hemorrhage complicated with autoimmune hemolytic anemia: A case report.

The Journal of international medical research2026 Jan

This study reported a case of disseminated intravascular coagulation secondary to postpartum hemorrhage complicated by autoimmune hemolytic anemia. A pregnant woman in her early 40s was admitted to The Third Central Hospital of Tianjin with regular contractions in July 2022. The direct antiglobulin test was positive for IgG and C3d. Following the delivery of a baby girl, she developed severe postpartum hemorrhage, and the obstetric disseminated intravascular coagulation score exceeded 8 points. She was diagnosed with disseminated intravascular coagulation secondary to postpartum hemorrhage and warm-antibody type autoimmune hemolytic anemia (IgG + C3). The patient underwent methylprednisone therapy, emergency selective bilateral uterine artery embolization, and transfusion with suspended and washed red blood cells. Subsequently, routine coagulation parameters normalized, and the urine color gradually cleared. Therefore, glucocorticoids, uterine artery embolization, and blood transfusion may be effective for managing disseminated intravascular coagulation secondary to postpartum hemorrhage complicated by autoimmune hemolytic anemia.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC2 artigos no totalmostrando 91

2026

A Complex Case of Anti-e Mimicking Autoantibody Development Leading to Warm Autoimmune Hemolytic Anemia: Case Report.

Acta haematologica
2026

When Warm Meets Cold: Mixed-Type Autoimmune Hemolytic Anemia Revealing an Underlying Autoimmune Disorder.

Cureus
2026

A Rare Autoimmune Hemolytic Overlap: Coombs-Positive Pernicious Anemia.

Cureus
2026

Transfusion-induced hemolysis in warm autoimmune hemolytic anemia with autoantibodies that have anti-e specificity: a case report and systematic review of the literature.

Therapeutic advances in hematology
2026

Disseminated intravascular coagulation secondary to postpartum hemorrhage complicated with autoimmune hemolytic anemia: A case report.

The Journal of international medical research
2025

A Case Report of a 14-year-old Boy with Mixed-type Autoimmune Hemolytic Anemia.

Annals of African medicine
2025

Mixed-type autoimmune hemolytic anaemia complicated by acute cerebral infarction: a case report.

Frontiers in medicine
2025

Bone marrow microenvironment in autoimmune hemolytic anemia: from trephine biopsy to single cell RNA sequencing.

Signal transduction and targeted therapy
2025

Successful Dostarlimab Rechallenge Following Pembrolizumab-Induced Autoimmune Hemolytic Anemia: A Case Report.

Clinical case reports
2025

Autoimmune Hemolytic Anemia as an Initial Manifestation of Splenic Marginal Zone Lymphoma.

Cureus
2025

The Clinical Significance of Warm Autoantibodies during Pregnancy.

Transfusion medicine (Oxford, England)
2025

Mixed Autoimmune Hemolytic Anemia: A Systematic Review of Epidemiology, Clinical Characteristics, Therapies, and Outcomes.

American journal of hematology
2025

Prevalence of systemic lupus erythematosus in autoimmune hemolytic anemia patients based on coombs test results.

European journal of medical research
2025

The treatment of autoimmune hemolytic anemia with complement inhibitor iptacopan: a case report.

Frontiers in medicine
2025

Clinical Characteristics of Patients With Idiopathic Multicentric Castleman Disease Complicated by Autoimmune Hemolytic Anemia.

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
2025

Insight Into Aetiology and Severity of Hemolysis Associated with Immunoproteins on Red Cell Surface in Direct Antiglobulin Test Positive Auto-immune Hemolytic Anemia.

Indian journal of hematology &amp; blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
2024

Very low doses of rituximab in autoimmune hemolytic anemia-an open-label, phase II pilot trial.

Frontiers in medicine
2024

Autoimmune haemolytic anaemias.

Nature reviews. Disease primers
2024

Parsaclisib for the treatment of primary autoimmune hemolytic anemia: Results from a phase 2, open-label study.

American journal of hematology
2024

Mixed autoimmune hemolytic anemia as the initial presentation of systemic lupus erythematosus: A case report and review.

EJHaem
2024

[Current recommendations for the diagnosis and treatment of autoimmune hemolytic anemia based on etiology and pathology].

[Rinsho ketsueki] The Japanese journal of clinical hematology
2024

Sutimlimab for Cold Agglutinin Disease.

Journal of the advanced practitioner in oncology
2024

Cold Agglutinin Disease: A Rare Paraneoplastic Manifestation of a Thyroid Malignancy.

Cureus
2024

[The treatment strategies of autoimmune hemolytic anemia].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
2024

Diagnosis and management of Evans syndrome in adults: first consensus recommendations.

The Lancet. Haematology
2024

[Cold agglutinin disease: pathology, diagnosis, and treatment].

[Rinsho ketsueki] The Japanese journal of clinical hematology
2024

Role of direct antiglobulin test in anemia under evaluation: Its prevalence, laboratory workup, and significance in further patient management-A study from eastern India.

Indian journal of pathology &amp; microbiology
2024

Hemolytic Anemia as a Provoking Factor for Recurrent Venous Thromboembolism: A Case Report.

Cureus
2024

Clinical profile and serological correlation with haemolysis in DAT-positive autoimmune haemolytic anaemia patients in Bangladesh.

Pathology
2023

Suspect the Unexpected: A Rare Association of Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis with Visceral Leishmaniasis: A Case Report and Review of Literature.

EJIFCC
2024

Successful Treatment of Warm Autoimmune Hemolytic Anemia with a Positive Donath-Landsteiner Test Using Rituximab.

Internal medicine (Tokyo, Japan)
2023

Antibody based therapeutics for autoimmune hemolytic anemia.

Expert opinion on biological therapy
2023

Total arch replacement for an aortic arch aneurysm with cold agglutinin disease after rituximab and plasmapheresis.

Journal of cardiothoracic surgery
2023

Systemic Lupus Erythematosus and Antiphospholipid Syndrome Accompanied by Mixed-Type Autoimmune Hemolytic Anemia.

Case reports in rheumatology
2023

Genome-wide DNA methylation profiles analysis in primary warm autoimmune hemolytic anemia patients.

Hematology (Amsterdam, Netherlands)
2023

Molecular pharmacology in complement-mediated hemolytic disorders.

European journal of haematology
2023

Mixed Warm and Cold Autoimmune Hemolytic Anemia With Concomitant Immune Thrombocytopenia Following Recent SARS-CoV-2 Infection and Ongoing Rhinovirus Infection.

Cureus
2023

Exacerbation of autoimmune hemolytic anemia associated with pure red cell aplasia after COVID-19: A case report.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
2024

Autoimmune Hemolytic Anemia in Children: Clinical Profile and Outcome.

Indian journal of pediatrics
2023

Autoimmune haemolytic anaemia.

Medicina clinica
2022

Type O blood, the MCHC, and the reticulocyte count impact the early recurrence of primary warm-antibody autoimmune hemolytic anemia in children: A retrospective cohort analysis.

Frontiers in pediatrics
2022

New Therapies for the Treatment of Warm Autoimmune Hemolytic Anemia.

Transfusion medicine reviews
2023

Practical therapy for primary autoimmune hemolytic anemia in adults.

Clinical and experimental medicine
2022

[Thrombotic risk in autoimmune hemolytic anemia].

[Rinsho ketsueki] The Japanese journal of clinical hematology
2022

Autoimmune hemolytic anemia: causes and consequences.

Expert review of clinical immunology
2022

[Development of severe aplastic anemia during steroid therapy for autoimmune hemolytic anemia].

[Rinsho ketsueki] The Japanese journal of clinical hematology
2022

Survival in autoimmune hemolytic anemia remains poor, results from a nationwide cohort with 37 years of follow-up.

European journal of haematology
2022

COVID-19 and Immune-Mediated RBC Destruction.

American journal of clinical pathology
2021

Blood group discrepancy in mixed-type autoimmune hemolytic anemia in a pediatric patient.

Asian journal of transfusion science
2021

Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature.

Frontiers in immunology
2022

COVID-19-associated Evans syndrome: A case report and review of the literature.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
2021

An Uncharacteristic Presentation of Evans Syndrome Following Treatment With Dupilumab.

Cureus
2021

Cytomegalovirus-Associated Hemolytic Anemia in an Infant Born to a Mother with Lupus.

Neonatology
2021

A fluorometric erythrophagocytosis assay using differentiated monocytic THP-1 cells to assess the clinical significance of antibodies to red blood cells.

Vox sanguinis
2021

Clinical Profile and Severity of Hemolysis in Adult Patients of Primary Autoimmune Hemolytic Anemia and Their Response to Steroid: A Prospective Cohort Study from Single Institution.

Indian journal of hematology &amp; blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
2020

Autoimmune hemolytic anemia: current knowledge and perspectives.

Immunity &amp; ageing : I &amp; A
2020

Autoimmune Hemolytic Anemia After Cyanocobalamin Replacement in a Patient With a Previous Diagnosis of Pernicious Anemia: A Case Report.

Cureus
2020

Rapidly Exacerbating Autoimmune Hemolytic Anemia Together With Marked Cytokine Storm Triggered by Pneumonia Infection: A Case Report.

Frontiers in immunology
2020

[Evaluation of Efficacy and Safety of Blood Transfusion and Hormone Therapy in 40 Patients with Autoimmune Hemolytic Anemia].

Zhongguo shi yan xue ye xue za zhi
2020

Differential red blood cell age fractionation and Band 3 phosphorylation distinguish two different subtypes of warm autoimmune hemolytic anemia.

Transfusion
2020

Small Paroxysmal Nocturnal Hemoglobinuria Clones in Autoimmune Hemolytic Anemia: Clinical Implications and Different Cytokine Patterns in Positive and Negative Patients.

Frontiers in immunology
2020

Successful Treatment of a Korean Infant with Giant Cell Hepatitis with Autoimmune Hemolytic Anemia Using Rituximab.

Pediatric gastroenterology, hepatology &amp; nutrition
2022

Autoimmune hemolytic anemia in pregnancy: a challenge for maternal and fetal follow-up.

The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
2020

Fatal fulminant hemolysis-associated pulmonary embolism in mixed-type autoimmune hemolytic anemia: A case report.

Medicine
2020

Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting.

Blood reviews
2019

Efficacy and safety of second-line treatment in Thai patients with primary warm-type autoimmune hemolytic anemia.

Hematology (Amsterdam, Netherlands)
2020

Autoimmune haemolytic anaemias: A retrospective study of 93 patients.

Medicina clinica
2019

[Serological Characteristics of Patients with Autoimmune Hemoly-tic Anemia and Efficacy and Safety of Incompatible Transfusion of Red Blood Cells].

Zhongguo shi yan xue ye xue za zhi
2018

Autoimmune hemolytic anemia.

Hematology. American Society of Hematology. Education Program
2018

Anti-CD20 Treatment of Autoimmune Hemolytic Anemia Refractory to Corticosteroids and Azathioprine: A Pediatric Case Report and Mini Review.

Case reports in hematology
2017

Adsorption Technique in Pre-Transfusion Testing For Patients with Warm Type Autoimmune Hemolytic Anemia.

The Egyptian journal of immunology
2018

Cold Agglutinins in Peripheral Blood with Atypical Cells with an Owl-Eye Appearance in Bone Trephine.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
2017

Inflammatory Breast Cancer and Warm Antibody Autoimmune Hemolytic Anemia: A Rare Paraneoplastic Syndrome.

Journal of investigative medicine high impact case reports
2017

Plasmapheresis in a child with cold antibody autoimmune hemolytic anemia: case report.

Turk pediatri arsivi
2017

Rare presentation of mixed autoimmune hemolytic anemia in children: Report of 2 cases.

Journal of laboratory physicians
2018

Eryptosis in autoimmune haemolytic anaemia.

European journal of haematology
2017

Alloimmunization in autoimmune hemolytic anemia patient: The differential adsorption approach.

Asian journal of transfusion science
2016

Warm antibody autoimmune hemolytic anemia.

Hematology. American Society of Hematology. Education Program
2016

Resolution of Serologic Problems Due to Cold Agglutinins in Chronic Lymphocytic Leukemia.

Indian journal of hematology &amp; blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
2016

Fatal warm autoimmune hemolytic anemia in a child due to IgM-type autoantibodies.

Pediatrics international : official journal of the Japan Pediatric Society
2016

Clinical characteristics and long-term outcomes of warm-type autoimmune hemolytic anemia.

Hematology (Amsterdam, Netherlands)
2016

[Clinical profile of autoimmune hemolytic anemia with monoclonal gammopathy IgMκ].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
2016

Autoimmune Hemolytic Anemia in Children: Mayo Clinic Experience.

Journal of pediatric hematology/oncology
2016

Autoimmune Hemolytic Anemia and Hodgkin's Disease: An Unusual Pediatric Association.

Case reports in pediatrics
2015

Role of Complement in Autoimmune Hemolytic Anemia.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie
2015

Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie
2015

IL-33 reflects dynamics of disease activity in patients with autoimmune hemolytic anemia by regulating autoantibody production.

Journal of translational medicine
2015

Precautions surrounding blood transfusion in autoimmune haemolytic anaemias are overestimated.

Blood transfusion = Trasfusione del sangue
2015

[Autoimmune haemolytic anaemia: a review and report of four cases].

Orvosi hetilap
2015

Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy.

BioMed research international
2014

The effect of erythropoiesis-stimulating agents in patients with therapy-refractory autoimmune hemolytic anemia.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Anemia hemolítica autoimune, tipo quente.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Anemia hemolítica autoimune, tipo quente

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. A Complex Case of Anti-e Mimicking Autoantibody Development Leading to Warm Autoimmune Hemolytic Anemia: Case Report.
    Acta haematologica· 2026· PMID 41824628mais citado
  2. When Warm Meets Cold: Mixed-Type Autoimmune Hemolytic Anemia Revealing an Underlying Autoimmune Disorder.
    Cureus· 2026· PMID 41694896mais citado
  3. A Rare Autoimmune Hemolytic Overlap: Coombs-Positive Pernicious Anemia.
    Cureus· 2026· PMID 41625053mais citado
  4. Transfusion-induced hemolysis in warm autoimmune hemolytic anemia with autoantibodies that have anti-e specificity: a case report and systematic review of the literature.
    Therapeutic advances in hematology· 2026· PMID 41613625mais citado
  5. Disseminated intravascular coagulation secondary to postpartum hemorrhage complicated with autoimmune hemolytic anemia: A case report.
    The Journal of international medical research· 2026· PMID 41575164mais citado
  6. Delayed-Onset Autoimmune Hemolytic Anemia in Advanced HIV With Cerebral Toxoplasmosis.
    Cureus· 2026· PMID 41993768recente
  7. [Rapid response to linperlisib in relapsed/refractory autoimmune hemolytic anemia: a case report].
    Zhonghua Xue Ye Xue Za Zhi· 2026· PMID 41991318recente
  8. [Treatment practice and outcomes in 125 patients with autoimmune hemolytic anemia: a single-center retrospective analysis].
    Zhonghua Xue Ye Xue Za Zhi· 2026· PMID 41991308recente
  9. Case Report: Refractory cold agglutinin disease with hypersplenism: efficacy of splenectomy in a patient treated with sutimlimab.
    Front Immunol· 2026· PMID 41983131recente
  10. Zieve's Syndrome in a Patient With Alcohol Use Disorder and Alcohol-Associated Cirrhosis: A Case Report and Review of the Literature.
    Cureus· 2026· PMID 41982369recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:90033(Orphanet)
  2. MONDO:0019532(MONDO)
  3. GARD:7876(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Artigo Wikipedia(Wikipedia)
  6. Q7969590(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Anemia hemolítica autoimune, tipo quente
Compêndio · Raras BR

Anemia hemolítica autoimune, tipo quente

ORPHA:90033 · MONDO:0019532
Prevalência
1-9 / 100 000
Herança
Multigenic/multifactorial
CID-10
D59.1 · Outras anemias hemolíticas auto-imunes
CID-11
Início
All ages
Prevalência
0.0 (Europe)
MedGen
UMLS
C0272118
Repurposing
11 candidatos
azacitidineDNA methyltransferase inhibitor
cyanocobalaminmethylmalonyl CoA mutase stimulant|vitamin B
decitabineglucocorticoid receptor agonist
+8 outros
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades